184 related articles for article (PubMed ID: 17525188)
1. Modeling dose-response in amblyopia: toward a child-specific treatment plan.
Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2589-94. PubMed ID: 17525188
[TBL] [Abstract][Full Text] [Related]
2. Objectively monitored patching regimens for treatment of amblyopia: randomised trial.
Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
BMJ; 2007 Oct; 335(7622):707. PubMed ID: 17855283
[TBL] [Abstract][Full Text] [Related]
3. Treatment of unilateral amblyopia: factors influencing visual outcome.
Stewart CE; Fielder AR; Stephens DA; Moseley MJ
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3152-60. PubMed ID: 16123414
[TBL] [Abstract][Full Text] [Related]
4. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
Stewart CE; Moseley MJ; Stephens DA; Fielder AR
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3048-54. PubMed ID: 15326120
[TBL] [Abstract][Full Text] [Related]
5. Recovery of contour integration in relation to LogMAR visual acuity during treatment of amblyopia in children.
Chandna A; Gonzalez-Martin JA; Norcia AM
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4016-22. PubMed ID: 15505051
[TBL] [Abstract][Full Text] [Related]
6. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.
Loudon SE; Polling JR; Simonsz HJ
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):176-80. PubMed ID: 12644939
[TBL] [Abstract][Full Text] [Related]
7. The relationship between stereopsis and visual acuity after occlusion therapy for amblyopia.
Lee SY; Isenberg SJ
Ophthalmology; 2003 Nov; 110(11):2088-92. PubMed ID: 14597513
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance.
Awan M; Proudlock FA; Gottlob I
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1435-9. PubMed ID: 15790912
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of increasing patching for amblyopia.
; Wallace DK; Lazar EL; Holmes JM; Repka MX; Cotter SA; Chen AM; Kraker RT; Beck RW; Clarke MP; Lorenzana IJ; Petersen DB; Roberts JT; Suh DW
Ophthalmology; 2013 Nov; 120(11):2270-7. PubMed ID: 23755872
[TBL] [Abstract][Full Text] [Related]
10. A preliminary report about the relation between visual acuity increase and compliance in patching therapy for amblyopia.
Loudon SE; Polling JR; Simonsz HJ
Strabismus; 2002 Jun; 10(2):79-82. PubMed ID: 12221485
[TBL] [Abstract][Full Text] [Related]
11. Personalized versus standardized dosing strategies for the treatment of childhood amblyopia: study protocol for a randomized controlled trial.
Moseley MJ; Wallace MP; Stephens DA; Fielder AR; Smith LC; Stewart CE;
Trials; 2015 Apr; 16():189. PubMed ID: 25906974
[TBL] [Abstract][Full Text] [Related]
12. Amblyopia treatment outcomes.
Scott WE; Kutschke PJ; Keech RV; Pfeifer WL; Nichols B; Zhang L
J AAPOS; 2005 Apr; 9(2):107-11. PubMed ID: 15838435
[TBL] [Abstract][Full Text] [Related]
13. The effect of amblyopia treatment on stereoacuity.
Stewart CE; Wallace MP; Stephens DA; Fielder AR; Moseley MJ;
J AAPOS; 2013 Apr; 17(2):166-73. PubMed ID: 23622448
[TBL] [Abstract][Full Text] [Related]
14. [Amblyopia from anisometropia without strabismus].
Yuksel D; Spiritus M; Vandelannoitte S; Hoffmann D
Bull Soc Belge Ophtalmol; 1996; 263():69-73. PubMed ID: 9410409
[TBL] [Abstract][Full Text] [Related]
15. Compliance with occlusion therapy for childhood amblyopia.
Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR; ;
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6158-66. PubMed ID: 23882695
[TBL] [Abstract][Full Text] [Related]
16. Occlusion for amblyopia: a comprehensive survey of outcome.
Hiscox F; Strong N; Thompson JR; Minshull C; Woodruff G
Eye (Lond); 1992; 6 ( Pt 3)():300-4. PubMed ID: 1446765
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Interocular Suppression in Amblyopic Children during Electronically Monitored Occlusion Therapy: First Insight.
Kehrein S; Kohnen T; Fronius M
Strabismus; 2016 Jun; 24(2):51-62. PubMed ID: 27220458
[TBL] [Abstract][Full Text] [Related]
18. A prospective pilot study of treatment outcomes for amblyopia associated with myopic anisometropia.
Pang Y; Allison C; Frantz KA; Block S; Goodfellow GW
Arch Ophthalmol; 2012 May; 130(5):579-84. PubMed ID: 22232365
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of amblyopia after occlusion therapy.
Bhola R; Keech RV; Kutschke P; Pfeifer W; Scott WE
Ophthalmology; 2006 Nov; 113(11):2097-100. PubMed ID: 17074568
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of electronically monitored amblyopia treatment between 5 and 16 years of age: new insight into declining susceptibility of the visual system.
Fronius M; Cirina L; Ackermann H; Kohnen T; Diehl CM
Vision Res; 2014 Oct; 103():11-9. PubMed ID: 25130409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
